Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

New Fgf1a murine models of heart failure and metabolic syndrome developed

April 8, 2022

Elastrin Therapeutics closes funding round to advance development of lead candidate

April 8, 2022

Medshine Discovery patents new sGC activators

April 7, 2022

NPO-2270 ameliorates cardiac dysfunction more effectively than enalapril in models of HF

April 7, 2022

NOX2 inhibition reverses obesity-induced atrial fibrillation

April 6, 2022

BMP-9 is required for survival after acute myocardial infarction

April 6, 2022

Deleting protein switches macrophages to reduced-fat diet

March 31, 2022

MK-6158: sGC stimulator clinical candidate for pulmonary arterial hypertension

March 28, 2022

German researchers divulge nitric oxide production inhibitors

March 25, 2022

New rat model may shed light on mechanisms behind CSVD pathogenesis

March 17, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...